A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma

Condition:   Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma Interventions:   Drug: cabozantinib;   Drug: nivolumab Sponsor:   Memorial Sloan Kettering Cancer Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials